APA (7th ed.) Citation

AC, N., CD, M., S, R., H, A., AY, S., MK, S., . . . KS, R. (2017). Correction: Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo. PloS one, 12(4), e0175659. https://doi.org/10.1371/journal.pone.0175659

Chicago Style (17th ed.) Citation

AC, Nirvanappa, et al. "Correction: Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo." PloS One 12, no. 4 (2017): e0175659. https://doi.org/10.1371/journal.pone.0175659.

MLA (9th ed.) Citation

AC, Nirvanappa, et al. "Correction: Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo." PloS One, vol. 12, no. 4, 2017, p. e0175659, https://doi.org/10.1371/journal.pone.0175659.